288 related articles for article (PubMed ID: 33972504)
21. Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.
Xu-Monette ZY; Xiao M; Au Q; Padmanabhan R; Xu B; Hoe N; Rodríguez-Perales S; Torres-Ruiz R; Manyam GC; Visco C; Miao Y; Tan X; Zhang H; Tzankov A; Wang J; Dybkær K; Tam W; You H; Bhagat G; Hsi ED; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; van Krieken JH; Winter JN; Westin JR; Pham LV; Medeiros LJ; Rassidakis GZ; Li Y; Freeman GJ; Young KH
Cancer Immunol Res; 2019 Apr; 7(4):644-657. PubMed ID: 30745366
[TBL] [Abstract][Full Text] [Related]
22. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
[TBL] [Abstract][Full Text] [Related]
23. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
Rinaldi A; Mensah AA; Kwee I; Forconi F; Orlandi EM; Lucioni M; Gattei V; Marasca R; Berger F; Cogliatti S; Cavalli F; Zucca E; Gaidano G; Rossi D; Bertoni F
Br J Haematol; 2013 Oct; 163(2):194-204. PubMed ID: 23961875
[TBL] [Abstract][Full Text] [Related]
24. How we treat Richter syndrome.
Parikh SA; Kay NE; Shanafelt TD
Blood; 2014 Mar; 123(11):1647-57. PubMed ID: 24421328
[TBL] [Abstract][Full Text] [Related]
25. Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.
El Hussein S; Medeiros LJ; Gruschkus SK; Wei P; Schlette E; Fang H; Jelloul FZ; Wang W; Fiskus W; Kanagal-Shamanna R; Loghavi S; Yang H; Li S; Xu J; Tang Z; Thakral B; Jain N; Wierda WG; Patel K; Bhalla KN; Khoury JD
Virchows Arch; 2023 Jun; 482(6):1011-1019. PubMed ID: 36864257
[TBL] [Abstract][Full Text] [Related]
26. Chronic lymphocytic leukemia transformation into high-grade lymphoma: a description of Richter's syndrome in eight dogs.
Comazzi S; Martini V; Riondato F; Poggi A; Stefanello D; Marconato L; Albonico F; Gelain ME
Vet Comp Oncol; 2017 Jun; 15(2):366-373. PubMed ID: 26463596
[TBL] [Abstract][Full Text] [Related]
27. Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target.
Gould C; Lickiss J; Kankanige Y; Yerneni S; Lade S; Gandhi MK; Chin C; Yannakou CK; Villa D; Slack GW; Markham JF; Tam CS; Nelson N; Seymour JF; Dickinson M; Neeson PJ; Westerman D; Blombery P
Br J Haematol; 2021 Oct; 195(1):113-118. PubMed ID: 34426978
[TBL] [Abstract][Full Text] [Related]
28. Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.
Tadmor T; Shvidel L; Goldschmidt N; Ruchlemer R; Fineman R; Bairey O; Rahimi-Levene N; Herishanu Y; Yuklea M; Arad A; Aviv A; Polliack A
Anticancer Res; 2014 Feb; 34(2):785-90. PubMed ID: 24511013
[TBL] [Abstract][Full Text] [Related]
29. Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
Favini C; Talotta D; Almasri M; Andorno A; Rasi S; Adhinaveni R; Kogila S; Awikeh B; Schipani M; Boggione P; Mouhssine S; Ghanej J; Al Essa W; Mahmoud AM; Dondolin R; Alessa N; Margiotta Casaluci G; Boldorini R; Gattei V; Gaidano G; Moia R
Br J Haematol; 2022 Sep; 198(6):1016-1022. PubMed ID: 35829664
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.
Broséus J; Hergalant S; Vogt J; Tausch E; Kreuz M; Mottok A; Schneider C; Dartigeas C; Roos-Weil D; Quinquenel A; Moulin C; Ott G; Blanchet O; Tomowiak C; Lazarian G; Rouyer P; Chteinberg E; Bernhart SH; Tournilhac O; Gauchotte G; Lomazzi S; Chapiro E; Nguyen-Khac F; Chery C; Davi F; Hunault M; Houlgatte R; Rosenwald A; Delmer A; Meyre D; Béné MC; Thieblemont C; Lichter P; Ammerpohl O; Guéant JL; ; Guièze R; Martin-Subero JI; Cymbalista F; Feugier P; Siebert R; Stilgenbauer S
Nat Commun; 2023 Jan; 14(1):309. PubMed ID: 36658118
[TBL] [Abstract][Full Text] [Related]
31. Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia.
Grzywnowicz M; Zaleska J; Mertens D; Tomczak W; Wlasiuk P; Kosior K; Piechnik A; Bojarska-Junak A; Dmoszynska A; Giannopoulos K
PLoS One; 2012; 7(4):e35178. PubMed ID: 22532845
[TBL] [Abstract][Full Text] [Related]
32. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
33. Richter transformation with c-MYC overexpression: report of three cases.
Wang L; Aghel A; Peterson B; Wang-Rodriguez J; Wang HY; Zhao XF
Int J Clin Exp Pathol; 2015; 8(6):7540-6. PubMed ID: 26261666
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
Cordone I; Matutes E; Catovsky D
Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
[TBL] [Abstract][Full Text] [Related]
35. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL
Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928
[TBL] [Abstract][Full Text] [Related]
36. Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemia.
Tonino SH; van de Berg PJ; Yong SL; ten Berge IJ; Kersten MJ; van Lier RA; van Oers MH; Kater AP
Leuk Lymphoma; 2012 Sep; 53(9):1785-94. PubMed ID: 22397719
[TBL] [Abstract][Full Text] [Related]
37. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
38. PD-L1
Pollari M; Brück O; Pellinen T; Vähämurto P; Karjalainen-Lindsberg ML; Mannisto S; Kallioniemi O; Kellokumpu-Lehtinen PL; Mustjoki S; Leivonen SK; Leppä S
Haematologica; 2018 Nov; 103(11):1908-1914. PubMed ID: 30026337
[TBL] [Abstract][Full Text] [Related]
39. Molecular history of Richter syndrome: origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis.
Rossi D; Spina V; Forconi F; Capello D; Fangazio M; Rasi S; Martini M; Gattei V; Ramponi A; Larocca LM; Bertoni F; Gaidano G
Int J Cancer; 2012 Jun; 130(12):3006-10. PubMed ID: 21796624
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcome and prognostic factors of patients with Richter syndrome: real-world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC).
Abrisqueta P; Delgado J; Alcoceba M; Oliveira AC; Loscertales J; Hernández-Rivas JA; Ferrà C; Cordoba R; Yáñez L; Medina A; Motlló C; Iacoboni G; Villacampa G; González M; Bosch F
Br J Haematol; 2020 Sep; 190(6):854-863. PubMed ID: 32519351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]